Truist Financial Cuts National Health Investors (NYSE:NHI) Price Target to $72.00

National Health Investors (NYSE:NHIGet Free Report) had its target price decreased by equities researchers at Truist Financial from $78.00 to $72.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective would indicate a potential upside of 3.08% from the stock’s current price.

A number of other equities analysts have also weighed in on the stock. Bank of America initiated coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective for the company. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Finally, Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and a consensus price target of $75.33.

Check Out Our Latest Analysis on National Health Investors

National Health Investors Stock Up 1.5 %

NHI opened at $69.85 on Monday. The stock has a market capitalization of $3.17 billion, a P/E ratio of 24.00, a P/E/G ratio of 4.86 and a beta of 1.04. National Health Investors has a 12 month low of $51.59 and a 12 month high of $86.13. The business has a 50 day simple moving average of $76.02 and a 200-day simple moving average of $75.66. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.

National Health Investors (NYSE:NHIGet Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same period last year, the firm earned $1.08 EPS. National Health Investors’s revenue was up 1.7% compared to the same quarter last year. On average, equities analysts anticipate that National Health Investors will post 4.42 earnings per share for the current fiscal year.

Hedge Funds Weigh In On National Health Investors

Large investors have recently bought and sold shares of the business. Zimmer Partners LP bought a new position in shares of National Health Investors during the third quarter valued at approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in National Health Investors by 332.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock worth $20,370,000 after buying an additional 186,238 shares during the period. Charles Schwab Investment Management Inc. increased its position in National Health Investors by 17.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after buying an additional 123,596 shares during the period. Waterfront Capital Partners LLC acquired a new position in shares of National Health Investors during the third quarter valued at $10,097,000. Finally, Lee Danner & Bass Inc. acquired a new position in shares of National Health Investors during the second quarter valued at $5,089,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

(Get Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.